Stryker Corporation $SYK Stake Lifted by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Stryker Corporation (NYSE:SYK - Free Report) by 3.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 723,705 shares of the medical technology company's stock after acquiring an additional 24,421 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.19% of Stryker worth $251,980,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. United Financial Planning Group LLC bought a new position in shares of Stryker in the third quarter valued at approximately $27,000. Strive Asset Management LLC acquired a new stake in Stryker during the third quarter valued at approximately $30,000. ANTIPODES PARTNERS Ltd acquired a new stake in Stryker during the third quarter valued at approximately $34,000. Copia Wealth Management lifted its stake in Stryker by 181.6% during the third quarter. Copia Wealth Management now owns 107 shares of the medical technology company's stock valued at $40,000 after purchasing an additional 69 shares during the last quarter. Finally, WPG Advisers LLC lifted its stake in Stryker by 156.8% during the third quarter. WPG Advisers LLC now owns 113 shares of the medical technology company's stock valued at $42,000 after purchasing an additional 69 shares during the last quarter. 77.09% of the stock is currently owned by institutional investors.

Stryker Stock Up 1.5%

Shares of NYSE:SYK opened at $295.39 on Wednesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11. The company has a market cap of $113.13 billion, a PE ratio of 34.19, a price-to-earnings-growth ratio of 1.72 and a beta of 0.80. Stryker Corporation has a 52 week low of $290.17 and a 52 week high of $404.87. The firm has a 50 day simple moving average of $343.97 and a 200 day simple moving average of $356.28.

Stryker (NYSE:SYK - Get Free Report) last released its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The company had revenue of $6.02 billion during the quarter, compared to analysts' expectations of $6.34 billion. During the same quarter in the previous year, the company earned $2.84 EPS. The firm's quarterly revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, research analysts expect that Stryker Corporation will post 14.98 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts recently commented on the stock. Piper Sandler reissued an "overweight" rating on shares of Stryker in a research note on Tuesday, January 27th. UBS Group cut their target price on shares of Stryker from $400.00 to $380.00 and set a "neutral" rating for the company in a research note on Tuesday, March 17th. Robert W. Baird set a $385.00 target price on shares of Stryker in a research note on Friday. Wall Street Zen raised shares of Stryker from a "hold" rating to a "buy" rating in a research note on Saturday. Finally, Truist Financial reissued a "hold" rating and set a $330.00 target price (down from $380.00) on shares of Stryker in a research note on Monday. Sixteen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $395.48.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.